CVS Health (CVS) Projected to Post Earnings on Wednesday

CVS Health (NYSE:CVS - Get Free Report) is expected to post its quarterly earnings results before the market opens on Wednesday, February 12th. Analysts expect CVS Health to post earnings of $0.89 per share and revenue of $96.90 billion for the quarter. Investors interested in participating in the company's conference call can do so using this link.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business's revenue was up 6.3% on a year-over-year basis. During the same period last year, the company earned $2.21 earnings per share. On average, analysts expect CVS Health to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

CVS Health Stock Down 0.5 %

Shares of NYSE CVS traded down $0.29 during mid-day trading on Friday, reaching $53.95. 5,908,345 shares of the company's stock traded hands, compared to its average volume of 12,505,263. The stock has a market cap of $67.90 billion, a P/E ratio of 13.69, a PEG ratio of 0.62 and a beta of 0.61. The business has a 50-day simple moving average of $50.90 and a 200 day simple moving average of $56.02. CVS Health has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.93%. The ex-dividend date was Thursday, January 23rd. CVS Health's dividend payout ratio (DPR) is presently 67.51%.

Analyst Ratings Changes

Several research analysts recently weighed in on CVS shares. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price target on the stock in a report on Tuesday, December 3rd. Royal Bank of Canada dropped their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Thursday, January 30th. TD Cowen boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. Finally, Piper Sandler dropped their target price on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and a consensus price target of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.